Helping you secure long-term exclusivity

The life sciences landscape is changing. With big pharma developing generic capabilities and biosimilar approval now firmly established in Europe, you need to be ready for competition on your expired patents from the very beginning.

IP strategy is no longer just about filing as many applications as possible. It’s about preparing well-considered claims that remain relevant and enforceable throughout the life of the patent. Put another way, it’s about ring fencing your area of technology.

At Brookes Batchellor, we make it our business to be aware of European and US IP legislative developments as they happen – from decisions on combination SPCs and dosage regimes, to the protection afforded by claims to genetic material.

For us though, it’s not just about being first-rate patent attorneys. With academic backgrounds in biochemistry and molecular biology, we’ll stop at nothing to get under the skin of your innovation – because we’re genuinely fascinated by life sciences.

Protecting your investments

At Brookes Batchellor, our team of patent attorneys will help you:

• position your innovation strongly for the future by making sure you are covered by the right applications
• avoid unnecessary filings and costs by suggesting cost effective freedom-to-operate search strategies before your product is launched
• secure the best investments by conducting due diligence on behalf of VC firms
• build a long-term IP strategy by advising you on the patentability of any developments to your invention and recommending ways to extend your data exclusivity.

Ready to protect your invention?

Why not talk to one of us today? To find out how we can help protect your invention, contact one of the specialist attorneys listed below – there’s a contact form on their pages – or simply phone us today on 01892 510600.

Our people

Our experienced team of European patent attorneys includes:
David Bailey
Joanna Winwood
Mark Jolly